2019 Children's National–NIAID Symposium

Date: 
Friday, November 8, 2019 - 08:30 to 17:00
 
                             
 
We are excited to invite you to the 2nd Annual Children's National-NIAID Symposium! 
 
The Children's National and the National Institute of Allergy and Infectious Diseases (NIAID) partnership focuses on pediatric studies of significant interest to investigators at both institutions. This collaboration is framed and supported through a supplemental award to the Clinical and Translational Science Institute at Children's National (CTSI-CN), which is funded by the National Center for Advancing Translational Sciences (NCATS). As partners, Children's National and NIAID co-host an annual symposium. This year, the event will highlight other collaborative efforts between NIH and Children's National, and address genomics and care of children with immunologic diseases.  

Please register at bit.ly/cn-niaid-2019 by Wednesday, November 6, 2019.
  
Additional questions can be sent to CN-NIAIDPartnership@childrensnational.org. 
See below for more detail. 
 
We sincerely hope you'll join us for the 2nd Annual CN-NIAID Symposium. 
 
 
EVENT DETAILS
 
Please see below for directions to the NIH Main Campus (9000 Rockville Pike, Bethesda, Maryland 20892). All guests must go to the Gateway Center (Building 66) for security screening once arriving on campus.
 
The Symposium will be held at the NIH Natcher Conference Center (Building 45 on Center Drive).
 
Driving Directions 
 
  1. Take I-495 (Capital Beltway) westbound (Outer Loop) or northbound (Inner Loop).
  2. Take Exit 36 to Old Georgetown Road, south.
  3. Turn left onto West Cedar Lane.
  4. Yield right onto Rockville Pike.
  5. Follow signs to the Main Visitor’s entrance and park in MLP-11 Gateway Center Visitor Garage.
  6. Proceed to the Gateway Center (Building 66) for security screening.
  7. Proceed to the NIH Natcher Conference Center (Building 45), which is about 500 feet away from the Gateway Center.
Public Transportation
  1. Take the RED LINE to the NIH dedicated metro stop called Medical Center.
  2. The station's escalators come out on the NIH campus.
  3. Proceed to the Gateway Center (Building 66) for security screening.
  4. Proceed to the NIH Natcher Conference Center (Building 45), which is about 500 feet away from the Gateway Center.
Below is the link to the Gateway Center Map which is the entrance that visitors will enter through.
 
 
Know Before You Go
 
If you do not park at the MLP-11 garage, your vehicle will undergo inspection. Please allow additional time for that process. A small metered lot is available just outside the Natcher Center, but with limited spaces.
 
For complete visitor information, please visit nih.gov/about-nih/visitor-information
 
 
 
 
8:30 – 9:15 AM  
 
9:15 – 9:30 AM  
 
 
9:30 – 10:00 AM  
 

10:00 – 10:30 AM  
 
 
10:30 – 11:00 AM  
 
 
11:00 – 1:00 PM  
 
1:00 – 1:30 PM  
 
 
1:30 – 2:00 PM  
 
 
2:00 – 2:30 PM  
 
 
2:30 – 3:00 PM  
 
 
3:00 – 3:45 PM  



 
3:45 – 4:00 PM  
 
 
4:00 – 4:15 PM  
 
 
4:15 – 4:30 PM  
 
 
4:30 – 5:00 PM  
 
 
Registration and Breakfast
 
Welcome and Introduction
H. Clifford Lane, M.D., NIAID
 

Lessons and Benefits from Collaboration between the NIH and a Free-Standing Children’s Hospital
Marshall Summar, M.D., Children’s National Rare Disease Institute

The Hereditary Disorders of PropionylCoA and Cobalamin Metabolism – Past, Present, and Future
Charles Venditti, M.D., Ph.D., National Human Genome Research Institute Collaboration

The Road(s) to Genetic Precision Therapeutics in Pediatric Neuromuscular Disease: Opportunities and Challenges
Carsten Bonnemann, M.D., National Institute of Neurological Disorders and Stroke

Poster Session and Lunch

Genomic Diagnostics in Immunologic Diseases
Helen Su, M.D., Ph.D., National Institute of Allergy and Infectious Diseases

Update on Outcomes of Gene Therapy Clinical Trials for X-SCID and X-CGD, and Plans for Future Trials
Harry Malech, M.D., National Institute of Allergy and Infectious Diseases

Virus-specific T cell therapies:  Broadening applicability for PID patients
Catherine Bollard, M.D., Children’s National 

Using Genetic Testing to Guide Therapeutic Decisions in Primary Immune Deficiency Disease
Vanessa Bundy, M.D., Ph.D., Children’s National 

Panel Discussion – Moderator Lisa M. Guay-Woodford, M.D.
Drs. Su, Malech, Bollard, and Bundy  
Morgan Similuk, S.C.M., NIAID
Maren Chamorro, Parent Advocate

Underlying Mechanisms of Pediatric Food allergy: Focus on B cells
Adora Lin, M.D., Ph.D., Children’s National 

Pediatric Lyme Outcomes Study – Interim Update
Roberta DeBiasi, M.D., Children’s National 

Molecular Drivers and Opportunities in Neuroimmune Conditions of Pediatric Onset
Elizabeth Wells, M.D., Children’s National 

Closing Reception